| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/1999 | CA2159451C Unsaturated phosphonates derivatives of purines and pyrimidines |
| 04/13/1999 | CA2155236C Gas phase polymerization process |
| 04/13/1999 | CA2155129C Combinations of retroviral inhibitors |
| 04/13/1999 | CA2143216C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 04/13/1999 | CA2116799C Solid form xerostomia product |
| 04/13/1999 | CA2110437C 15-deoxysperqualin analogs, their method of preparation and their use in therapeutics |
| 04/13/1999 | CA2099667C Agent for treating hepatic diseases |
| 04/13/1999 | CA2057034C Onset hastened/enhanced antipyretic response |
| 04/13/1999 | CA2045553C Process for the preparation of vinyl ethers |
| 04/13/1999 | CA2044491C Novel process for industrial preparation of 4-chloro-3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol -1-yl) benzamide |
| 04/13/1999 | CA2044186C Novel process for industrial preparation of 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide from 2,3-dihydro 2-methyl 1h-indole and hydroxylamine-0-sulfonic acid |
| 04/13/1999 | CA2005987C Therapeutically active substituted benzimidazole and process for its preparation |
| 04/13/1999 | CA2005547C Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones |
| 04/13/1999 | CA1340496C Hydroxymethyl cyclobutyl purines |
| 04/13/1999 | CA1340493C Pyridone carboxylic acid derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same |
| 04/13/1999 | CA1340492C Novel naphthyridine-and quinoline-carboxylic acids as bacterial agents |
| 04/10/1999 | CA2249962A1 Anti-emetic agent |
| 04/10/1999 | CA2249867A1 Osteoporosis compounds |
| 04/10/1999 | CA2246632A1 Novel mure |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016888A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | WO1999016871A2 Nucleic acid catalysts with endonuclease activity |
| 04/08/1999 | WO1999016786A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds |
| 04/08/1999 | WO1999016779A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
| 04/08/1999 | WO1999016778A1 Cyclic phosphites and phosphates |
| 04/08/1999 | WO1999016771A1 Condensed benzothiopyranic compounds |
| 04/08/1999 | WO1999016770A1 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic |
| 04/08/1999 | WO1999016755A1 Novel angiogenesis inhibitors |
| 04/08/1999 | WO1999016753A2 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | WO1999016752A1 β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING |
| 04/08/1999 | WO1999016751A1 Benzamidine derivatives as factor xa inhibitors |
| 04/08/1999 | WO1999016750A1 Thrombin inhibitors |
| 04/08/1999 | WO1999016746A1 Aminoalkylphenol derivatives and related compounds |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016742A1 Processes and intermediates useful to make antifolates |
| 04/08/1999 | WO1999016741A2 Lipophilic diesters of chelating agents |
| 04/08/1999 | WO1999016472A1 Stable compositions containing biologically active components |
| 04/08/1999 | WO1999016470A1 Oral preparation |
| 04/08/1999 | WO1999016464A1 Modulation of nitric oxide production |
| 04/08/1999 | WO1999016456A1 Biologically active preparation, complex of such preparations and immuno-stimulation method |
| 04/08/1999 | WO1999016454A1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 04/08/1999 | WO1999016453A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016451A1 Use of vitamin d derivatives to enhance efficacy of cytotoxic agents |
| 04/08/1999 | WO1999016450A1 Budesonide for the treatment of cholestatic liver diseases |
| 04/08/1999 | WO1999016449A1 SPECIFIC STEADY-STATE R-TYPE Ca2+ CHANNEL BLOCKERS AND USE THEREOF |
| 04/08/1999 | WO1999016448A1 Sustained-release theophylline tablet |
| 04/08/1999 | WO1999016447A1 Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton |
| 04/08/1999 | WO1999016445A1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 04/08/1999 | WO1999016444A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 04/08/1999 | WO1999016443A1 Oral compositions of levosimendan |
| 04/08/1999 | WO1999016442A2 Sustained release tablet formulation to treat parkinson disease |
| 04/08/1999 | WO1999016440A1 Amorphous paroxetine composition |
| 04/08/1999 | WO1999016439A1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 04/08/1999 | WO1999016438A1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 04/08/1999 | WO1999016437A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 04/08/1999 | WO1999016436A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 04/08/1999 | WO1999016435A1 Pharmaceutical compositions containing ricinoleic acid and their use in anti-inflammatory and analgesic therapy |
| 04/08/1999 | WO1999016434A1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
| 04/08/1999 | WO1999016433A1 Remedy for hepatopathy |
| 04/08/1999 | WO1999016432A1 A drug for treating diabetic nephrosis |
| 04/08/1999 | WO1999016431A1 Mixtures of enantiomers of aminocyclohexylamides to produce simultaneous analgesia with local anaesthesia or antiarrhythmia |
| 04/08/1999 | WO1999016430A1 Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists |
| 04/08/1999 | WO1999016429A2 Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
| 04/08/1999 | WO1999016427A1 Active agent transport systems |
| 04/08/1999 | WO1999016426A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 04/08/1999 | WO1999016424A1 Anti-inflammatory pharmaceutical formulation |
| 04/08/1999 | WO1999016418A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 04/08/1999 | WO1999016417A1 Buccal, polar and non-polar spray or capsule |
| 04/08/1999 | WO1999016412A2 Non-irritating cosmetic and pharmaceutical compositions |
| 04/08/1999 | WO1999016411A1 Dermatologic preparation |
| 04/08/1999 | WO1999016375A1 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 04/08/1999 | WO1999016319A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
| 04/08/1999 | WO1999016313A1 2-methyl-thieno-benzodiazepine formulation |
| 04/08/1999 | WO1999016312A1 Method for treating sexual dysfunction |
| 04/08/1999 | WO1999016309A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 04/08/1999 | WO1999010322B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 04/08/1999 | WO1999006438A3 Compounds with anti-ks and anti-hiv activity |
| 04/08/1999 | WO1999006114A3 Use of taurolidine or taurultam for the manufacture of a medicament for the prevention of metastases |
| 04/08/1999 | WO1999005269A3 Transcriptional silencer protein nrf |
| 04/08/1999 | WO1999004793A3 Budipine in the treatment of inflammatory disorders of the nervous system |
| 04/08/1999 | WO1999004772A3 Use of levobupivacaine |
| 04/08/1999 | WO1999004771A3 Use of levobupivacaine |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | WO1999003823A3 Novel polyamine analogues as therapeutic and diagnostic agents |
| 04/08/1999 | WO1999000113A9 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 04/08/1999 | WO1998055638A9 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 04/08/1999 | WO1998055103A9 Anti-tumoral therapy agent |
| 04/08/1999 | WO1998054161A9 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/08/1999 | WO1998052549A3 Use of fumaric acid derivatives |
| 04/08/1999 | WO1998047494A3 Novel use of matrix metalloproteinase inhibitors |
| 04/08/1999 | DE19747546A1 Use of systemically administrable water-soluble antioxidant |
| 04/08/1999 | DE19743681A1 Use of endothelin receptor antagonists to prevent transplant rejection |
| 04/08/1999 | DE19743435A1 Benzamidinderivate Benzamidine derivatives |
| 04/08/1999 | DE19740983A1 Solid oral formulation based on ephedrine and similar compounds containing fats or gel forming agents and surfactants making isolation difficult |
| 04/08/1999 | CA2305781A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | CA2305686A1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | CA2305568A1 Benzamidinderivates |
| 04/08/1999 | CA2305206A1 Therapeutics for hepatic diseases |